ACS CAN has released the annual report that rates each state on their public policies in 10 issue areas that can help fight cancer, prevent cancer, and make life better for patients.
WASHINGTON, DC March 23, 2016 The American Cancer Society Cancer Action Network (ACS CAN) this week urged the Food and Drug Administration (FDA) to address safety concerns associated with indoor tanning and finalize the proposed rules as soon as possible to better protect adolescents from one of
December 18, 2015 The Food and Drug Administration (FDA) released two proposed regulations today that would prohibit tanning device use by minors under 18, strengthen the warning labels noting the danger of sun lamps and require those who tan to sign a form acknowledging the dangers of the devices every six months.
WASHINGTON, D.C. Aug. 6, 2015 A majority of states are not measuring up on legislative solutions that prevent and fight cancer, according to a report released today by the American Cancer Society Cancer Action Network (ACS CAN).
Following is a statement from the American Cancer Society Cancer Action Network (ACS CAN) commending the Food and Drug Administration (FDA) for finalizing its order to reclassify indoor tanning devices from a class I to a class II medical device, imposing greater control over their manufacture and distribution.
The American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), submitted comments today to the Centers for Disease Control and Prevention (CDC) commending the agency and the Office of the Surgeon General for considering a response to the public health problem of skin cancer.
WASHINGTON, D.C. August 15, 2013 A majority of states are not measuring up on legislative solutions that prevent and fight cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN).
WASHINGTON, DC August 1, 2013 The American Cancer Society Cancer Action Network (ACS CAN) today submitted comments to the Food and Drug Administration (FDA) commending the agency for its proposal to reclassify tanning devices to address safety concerns associated with indoor tanning, but called f
WASHINGTON, D.C. May 6, 2012 ACS CAN applauds the Food and Drug Administration (FDA) 's announcement today that it will reclassify tanning beds from low- to moderate-risk products.
WASHINGTON, D.C. December 13, 2012 The American Cancer Society Cancer Action Network (ACS CAN) is calling on the Department of Health and Human Services (HHS) to expedite its review of the current tanning bed classification at the Food and Drug Administration (FDA).